The immunopathogenesis of Entamoeba histolytica

Experimental Parasitology

Volumn 126, Issue 3, 2010, Pages 366-380

  Mortimer, Leanne ^a   Chadee, Kris ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Amebiasis; Amebic colitis; Amebic liver abscess; Commensal microorgansim; Dysentery; Entamoeba histolytica; Immune response; Immunity; Immunopathogenesis; Mucosal immune response; Pathogenesis

Indexed keywords

CYSTEINE PROTEINASE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 8; TOLL LIKE RECEPTOR; COMPLEMENT; SECRETORY IMMUNOGLOBULIN;

ADAPTIVE IMMUNITY; AMEBIASIS; ANTIGEN PRESENTING CELL; ARTICLE; CAPPING PHENOMENON; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ADHESION; CELL INVASION; CELL PROTECTION; COMPLEMENT ACTIVATION; CYTOKINE PRODUCTION; ENTAMOEBA HISTOLYTICA; GRANULOMA; HOST PARASITE INTERACTION; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INFLAMMATION; INNATE IMMUNITY; INTESTINE EPITHELIUM CELL; LAMINA PROPRIA; LIVER ABSCESS; LIVER AMEBIASIS; MICROBIAL COLONIZATION; MUCOSAL IMMUNITY; NATURAL KILLER CELL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TROPHOZOITE; ANIMAL; HUMAN; IMMUNOLOGY; INTESTINE MUCOSA; MACROPHAGE; METABOLISM; MORTALITY; NATURAL KILLER T CELL; NEUTROPHIL; PARASITOLOGY; PATHOGENICITY; PATHOLOGY; T LYMPHOCYTE;

ANIMALS; COMPLEMENT SYSTEM PROTEINS; ENTAMOEBA HISTOLYTICA; ENTAMOEBIASIS; HOST-PARASITE INTERACTIONS; HUMANS; IMMUNOGLOBULIN A, SECRETORY; INTERLEUKIN-10; INTESTINAL MUCOSA; MACROPHAGES; NATURAL KILLER T-CELLS; NEUTROPHILS; T-LYMPHOCYTES;

ENTAMOEBA HISTOLYTICA; PROTOZOA;

EID: 77956249523     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2010.03.005     Document Type: Article

References (155)

1. Abd-Alla M.D., Jackson T.F., Rogers T., Reddy S., Ravdin J.I. Mucosal immunity to asymptomatic Entamoeba histolytica and Entamoeba dispar infection is associated with a peak intestinal anti-lectin immunoglobulin A antibody response. Infection and Immunity 2006, 74:3897-3903.
2. Abreu M.T., Vora P., Faure E., Thomas L.S., Arnold E.T., Arditi M. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. Journal of Immunology 2001, 167:1609-1616.
3. Adams E.B., MacLeod I.N. Invasive amebiasis I. Amebic dysentery and its complications. Medicine 1977, 56:315-323.
4. Adams E.B., MacLeod I.N. Invasive amebiasis II. Amebic liver abscess and its complications. Medicine 1977, 56:325-334.
5. Ali I.K., Utpal Mondal U., Roy S., Haque R., Petri W.A., Clark C.G. Evidence for a link between parasite genotype and outcome of infection with Entamoeba histolytica. Journal of Clinical Microbiology 2007, 45:285-289.
6. Ali I.K., Solaymani-Mohammadi S., Akhter J., Roy S., Gorrini C., Calderaro A., Parker S.K., Haque R., Petri W.A., Clark C.G. Tissue invasion by Entamoeba histolytica: evidence of genetic selection and/or DNA reorganization events in organ tropism. PLoS Neglected Tropical Diseases 2008, 2:e219.
7. Annacker O., Coombes J.L., Malmstrom V., Uhlig H.H., Bourne T., Johansson-Lindbom B., Agace W.W., Parker C.M., Powrie F. Essential role for CD103 in the T-cell-mediated regulation of experimental colitis. Journal of Experimental Medicine 2005, 202:1051-1061.
8. Artis D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nature Reviews Immunology 2008, 8:411-420.
9. + Cells. Infection and Immunity 2005, 73:4522-4529.
10. Ayeh-Kumi P.F., Ali I.M., Lockhart L.A., Gilchrist C.A., Petri W.A., Haque R. Entamoeba histolytica: genetic diversity of clinical isolates from Bangladesh as demonstrated by polymorphisms in the serine-rich gene. Experimental Parasitology 2001, 99:80-88.
11. Baxt L.A., Baker R.P., Singh U., Urban S. An Entamoeba histolytica rhomboid protease with atypical specificity cleaves a surface lectin involved in phagocytosis and immune evasion. Genes and Development 2008, 22:1636-1646.
12. Belkaid Y., Oldenhove G. Tuning microenvironments: induction of regulatory T cells by dendritic cells. Immunity 2008, 29:362-371.
13. Bettelli E., Oukka M., Kuchroo V.K. TH-17 cells in the circle of immunity and autoimmunity. Nature Immunology 2007, 8:345-350.
14. Bhattacharya A., Arya R., Clark C.G., Ackers J.P. Absence of lipophosphoglycan-like glycoconjugates in Entamoeba dispar. Parasitology 2000, 120:31-35.
15. Boniface K., Bak-Jensen K.S., Li Y., Blumenschein W.M., McGeachy M.J., McClanahan T.K., McKenzie B.S., Kastelein R.A., Cua D.J., de Waal Malefyt R. Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling. Journal of Experimental Medicine 2009, 206:535-548.
16. Bracha R., Mirelman D. Virulence of Entamoeba histolytica: trophozoites effects of bacteria, microaerobic conditions, and metronidazole. Journal of Experimental Medicine 1984, 160:353-358.
17. Braga L., Ninomiya H., McCoy J.J., Eacker S., Wiedmer T., Pham C., Wood S., Sims P.J., Petri W.A. Inhibition of the complement membrane attack complex by the galactose-specific adhesion of Entamoeba histolytica. Journal of Clinical Investigation 1992, 90:1131-1137.
18. Bruchhaus I., Tannich E. Induction of the iron-containing superoxide dismutase in Entamoeba histolytica by a superoxide anion-generating system or by iron chelation. Molecular Biochemical Parasitology 1994, 67:281-288.
19. Bruchhaus I., Tannich E. Identification of an Entamoeba histolytica gene encoding a protein homologous to prokaryotic disulphide oxidoreductases. Molecular and Biochemical Parasitology 1995, 70:187-191.
20. Bruchhaus I., Richter S., Tannich E., Jacobs T., Leippe M. Recombinant expression and biochemical characterization of an NADPH: flavin oxidoreductase from Entamoeba histolytica. Biochemical Journal 1998, 330:1217-1221.
21. Bruchhaus I., Loftus B.J., Hall N., Tannich E. The intestinal protozoan parasite Entamoeba histolytica contains 20 cysteine protease genes, of which only a small subset is expressed during in vitro cultivation. Eukaryotic Cell 2003, 2:501-509.
22. Burchard G.D., Prange G., Mirelman D. Interactions between trophozoites of Entamoeba histolytica and the human intestinal cell line HT-29 in the presence and absence of leukocytes. Parasitology Research 1993, 79:140-145.
23. Calderón J., de Lourdes Muňoz M., Acosta H.M. Surface redistribution and release of antibody-induced caps in entamoebae. Journal of Experimental Medicine 1980, 151:184-193.
24. Campbell D., Gaucher D., Chadee K. Serum from Entamoeba histolytica-infected gerbils selectively suppresses T cell proliferation by inhibiting Interleukin-2 production. Journal of Infectious Diseases 1999, 179:1495-1501.
25. Cerutti A., Rescigno M. The biology of intestinal immunoglobulin A responses. Immunity 2008, 28:740-750.
26. Chadee K., Meerovitch E. The pathogenesis of experimentally induced amebic liver abscess in the gerbil (Meriones unguiculatus). American Journal of Pathology 1984, 117:71-80.
27. Chadee K., Meerovitch E. Entamoeba histolytica: early progressive pathology in the cecum of the gerbil (Meriones unguiculatus). American Journal of Tropical Medicine and Hygiene 1985, 34:283-291.
28. Chadee K., Petri W.A., Innes D.J., Ravdin J.I. Rat and human colonic mucins bind to and inhibit adherence lectin of Entamoeba histolytica. Journal Clinical Investigation 1987, 80:1245-1254.
29. Charo I.F., Ransohoff R.M. The many roles of chemokines and chemokine receptors in inflammation. The New England Journal of Medicine 2006, 354:610-621.
30. Choi M., Sajed D., Poole L., Hirata K., Herdman S., Torian B.E., Reed S.L. An unusual surface peroxiredoxin protects invasive Entamoeba histolytica from oxidant attack. Molecular and Biochemical Parasitology 2005, 143:80-89.
31. + regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. Journal of Experimental Medicine 2007, 204:1757-1764.
32. Crispe I.N. The liver as a lymphoid organ. Annual Reviews of Immunology 2009, 27:147-163.
33. Davis P.H., Zhang X., Guo J., Townsend R.R., Stanley S.L. Comparative proteomic analysis of two Entamoeba histolytica strains with different virulence phenotypes identifies peroxiredoxin as an important component of amoebic virulence. Molecular Microbiology 2006, 61:1523-1532.
34. Denis M., Chadee K. In vitro and in vivo studies of macrophage functions in amebiasis. Infection and Immunity 1988, 56:3126-3131.
35. Denis M., Chadee K. Human neutrophils activated by interferon-gamma and tumour necrosis factor-alpha kill Entamoeba histolytica trophozoites in vitro. Journal of Leukocyte Biology 1989, 46:270-274.
36. Dey I., Chadee K. Prostaglandin E2 produced by Entamoeba histolytica binds to EP4 receptors and stimulates interleukin-8 production in human colonic cells. Infection and Immunity 2008, 76:5158-5163.
37. Dey I., Keller K., Belley A., Chadee K. Identification and characterization of a cyclooxygenase-like enzyme from Entamoeba histolytica. Proceedings of the National Academy of Sciences of the USA 2003, 100:13561-13566.
38. Duggal P., Haque R., Roy S., Mondal D., Sack R.B., Farr B.M., Beaty T.H., Petri W.A. Influence of human leukocyte antigen class II alleles on susceptibility to Entamoeba histolytica infection in Bangladeshi children. Journal of Infectious Diseases 2004, 189:520-526.
39. Eckmann L., Reed S.L., Smith J.R., Kagnoff M.F. Entamoeba histolytica trophozoites induce an inflammatory cytokine response by cultured human cells through the paracrine action of cytolytically released interleukin-Iα. Journal of Clinical Investigation 1995, 96:1269-1279.
40. Ellyson J.H., Bezmalinovic Z., Parks S.N., Lewis F.R. Necrotizing amebic colitis: a frequently fatal complication. American Journal of Surgery 1986, 152:21-26.
41. Elnkave K., Siman-Tov R., Ankri S. Consumption of l-arginine mediated by Entamoeba histolytica l-arginase (EhArg) inhibits amoebicidal activity and nitric oxide production by activated macrophages. Parasite Immunology 2003, 25:597-608.
42. Espinosa-Cantellano M., Martínez-Palomo A. Pathogenesis of intestinal amebiasis: from molecules to disease. Clinical Microbiology Reviews 2000, 13:318-331.
43. Fagarasan S., Honjo T. Intestinal IgA synthesis: regulation of front-line body defenses. Nature Reviews Immunology 2003, 3:63-72.
44. Faria A.M., Weiner H.L. Oral tolerance. Immunological Reviews 2005, 206:232-259.
45. Galván-Moroyoqui J.M., Domínguez-Robles M., Franco E., Meza I. The interplay between Entamoeba and Enteropathogenic bacteria modulates epithelial cell damage. PLoS Neglected Tropical Diseases 2008, 2:e266.
46. Garcia-Nieto R.M., Rico-Mata R., Arias-Negrete S., Avila E.E. Degradation of human secretory IgA1 and IgA2 by Entamoeba histolytica surface-associated proteolytic activity. Parasitology International 2008, 57:417-423.
47. Gasque P. Complement: a unique innate immune sensor for danger signals. Molecular Immunology 2004, 41:1089-1098.
48. Gay N.J., Gangloff M. Structure and function of toll receptors and their ligands. Annual Review of Biochemistry 2007, 76:141-165.
49. Ghadirian E., Somerfield S.D., Kongshavn P.A. Susceptibility of Entamoeba histolytica to oxidants. Infection and Immunity 1986, 51:263-267.
50. Gordon S. Alternative activation of macrophages. Nature Reviews Immunology 2003, 3:23-35.
51. Grazia Roncarolo M., Bacchetta R., Bordignon C., Narula S., Levings M.K. Type 1 T regulatory cells. Immunological Reviews 2001, 182:68-79.
52. Guerrant R.L., Brush J., Ravdin J.I., Sullivan J.A., Mandell G.L. Interaction between Entamoeba histolytica and human polymorpho-nuclear neutrophils. Journal of Infectious Diseases 1981, 143:83-93.
53. Guo X., Stroup S.E., Houpt E. Persistence of Entamoeba histolytica infection in CBA mice owes to intestinal IL-4 production and inhibition of protective IFN-γ. Mucosal Immunology 2008, 1:139-146.
54. Hamano S., Asgharpour A., Stroup S.E., Wynn T.A., Leiter E.H., Houpt E. Resistance of C57BL/6 mice to amoebiasis is mediated by nonhemopoietic cells but requires hemopoietic IL-10 production. Journal of Immunology 2006, 177:1208-1213.
55. Hamelmann C., Foerster B., Burchard G.D., Shetty N., Horstmann R.D. Induction of complement resistance in cloned pathogenic Entamoeba histolytica. Parasite Immunology 1993, 15:223-228.
56. Haque R., Ali I.M., Sack R.B., Farr B.M., Ramakrishnam G., Petri W.A. Amebiasis and mucosal IgA antibody against the Entamoeba histolytica adherence lectin in Bangladeshi children. Journal of Infectious Diseases 2001, 183:1787-1793.
57. Haque R., Duggal P., Ali I.M., Hossain M.B., Mondal D., Sack R.B., Farr B.M., Petri W.A. Innate and acquired resistance to amebiasis in Bangladeshi children. Journal of Infectious Diseases 2002, 186:547-552.
58. Haque R., Huston C.D., Hughes, Houpt E., Petri W.A. Current concepts: amebiasis. The New England Journal of Medicine 2003, 348:1565-1573.
59. Haque R., Mondal D., Duggal P., Kabirm M., Roy S., Farr B.M., Sack R.B., Petri W.A. Entamoeba histolytica infection in children and protection from subsequent amebiasis. Infection and Immunity 2006, 74:904-909.
60. Haque R., Mondal D., Shu J., Roy S., Kabir M., Davids A., Guggal P., Petri W.A. Correlation of interferon-γ production by peripheral blood mononuclear cells with childhood malnutrition and susceptibility to amebiasis. American Journal of Tropical Medicine and Hygiene 2007, 76:340-344.
61. Hickey M.J., Kubes P. Intravascular immunity: the host-pathogen encounter in blood vessels. Nature Reviews Immunology 2009, 9:364-375.
62. + T cells. Journal of Immunology 2002, 169:4496-4503.
63. Houpt E., Barroso L., Lockhart L., Wright R., Cramer C., David Lyerly D., Petri W.A. Prevention of intestinal amebiasis by vaccination with the Entamoeba histolytica Gal/GalNac lectin. Vaccine 2004, 22:611-617.
64. Huston C.D., Boettner D.R., Miller-Sims V., Petri W.A. Apoptotic killing and phagocytosis of host cells by the parasite Entamoeba histolytica. Infection and Immunity 2003, 71:964-972.
65. Ivory C.P., Chadee K. Activation of dendritic cells by the Gal-lectin of Entamoeba histolytica drives Th1 responses in vitro and in vivo. European Journal of Immunology 2007, 37:385-394.
66. Ivory C.P., Prystajecky M., Jobin C., Chadee K. Toll-like receptor 9-dependent macrophage activation by Entamoeba histolytica DNA. Infection and Immunity 2008, 76:289-297.
67. Iwata M., Hirakiyama A., Eshima Y., Kagechika H., Kato C., Song S.Y. Retinoic acid imprints gut-homing specificity on T cells. Immunity 2004, 21:527-538.
68. Jacobs T., Bruchhaus I., Dandekar T., Tannich E., Leippe M. Isolation and molecular characterization of a surface-bound proteinase of Entamoeba histolytica. Molecular Microbiology 1998, 27:269-276.
69. + dendritic cells in the regulation of tissue-selective T-cell homing. Journal of Experimental Medicine 2005, 202:1063-1073.
70. Kammanadiminti S.J., Chadee K. Suppression of NF-κB Activation by Entamoeba histolytica in intestinal epithelial cells is mediated by heat shock protein 27. Journal of Biological Chemistry 2006, 281:26112-26120.
71. Kammanadiminti S.J., Mann B.J., Dutil L., Chadee K. Regulation of toll-like receptor-2 expression by the Gal-lectin of Entamoeba histolytica. The FASEB Journal 2003, 8:155-157.
72. Kammanadiminti S.J., Dey I., Chadee K. Induction of monocyte chemotactic protein-1 in colonic epithelial cells by Entamoeba histolytica is mediated via the phosphatidylinositol 3-kinase/p65 pathway. Infection and Immunity 2007, 75:1765-1770.
73. Kawaguchi R., Yu J., Honda J., Hu J., Whitelegge J., Ping P., Wiita P., Bolk D., Sun H. A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A. Science 2007, 315:820-825.
74. Kelsall B.L., Ravdin J.I. Degradation of human immunoglobulin A by Entamoeba histolytica. Journal of Infectious Diseases 1993, 168:1319-1322.
75. Köhl J. Anaphylatoxins and infectious and non-infectious inflammatory diseases. Molecular Immunology 2001, 38:175-187.
76. Korn T., Bettelli E., Oukka M., Kuchroo V.K. IL-17 and Th17 cells. Annual Review of Immunology 2009, 27:485-517.
77. + T cells. Immunology Letters 2007, 108:183-188.
78. Lauwaet T., Oliveira M., De Bruyne G., Bruchhaus I., Duchêne M., Mareel M., Leroy A. Entamoeba histolytica trophozoites transfer lipophosphopeptidoglycans to enteric cell layers. International Journal for Parasitology 2004, 34:549-556.
79. Lemosa H.P., Grespana R., Vieiraa S.M., Cunhaa T.M., Verri W.A., Fernandesa K.S., Soutoa F.O., McInnesc I.B., Ferreiraa S.H., Liewc F.Y., Cunhaa F.Q. Prostaglandin mediates IL-23/IL-17-induced neutrophil migration in inflammation by inhibiting IL-12 and IFN production. Proceedings of the National Academy of Sciences 2009, 106:5954-5959.
80. Leroy A., De Bruyne G., Mareel M., Nokkaew C., Bailey G., Nelis H. Contact-dependent transfer of the galactose-specific lectin of Entamoeba histolytica to the lateral surface of enterocytes in culture. Infection and Immunity 1995, 63:4253-4260.
81. Lidell M.E., Moncada D., Chadee K., Hansson G.C. Entamoeba histolytica cysteine proteases cleave the MUC2 mucin in its C-terminal domain and dissolve the protective colonic mucus gel. Proceedings of the National Academy of Sciences of USA 2006, 103:9298-9303.
82. Lin J.Y., Chadee K. Macrophage cytotoxicity against Entamoeba histolytica trophozoites is mediated by nitric oxide from l-arginine. Journal of Immunology 1992, 148:3999-4005.
83. Lotter H., Zhang T., Seydel K.B., Stanley S.L., Tannich E. Identification of an epitope on the Entamoeba histolytica 170-kD lectin conferring antibody-mediated protection against invasive amebiasis. Journal of Experimental Medicine 1997, 185:1793-1801.
84. Lotter H., Jacobs T., Gaworski I., Tannich E. Sexual dimorphism in the control of amebic liver abscess in a mouse model of disease. Infection and Immunity 2006, 74:118-124.
85. Lotter H., Gonzlez-Roldán N., Lindner B., Winau F., Isibasi A., Moreno-Lafont M., Ulmer A.J., Holst O., Tannich E., Jacobs T. Natural killer T cells activated by a lipopeptidophosphoglycan from Entamoeba histolytica are critically important to control amebic liver abscess. PLoS Pathogens 2009, 5:e1000434.
86. Macpherson A.J., McCoy K.D., Johansen F., Brandtzaeg P. The immune geography of IgA induction and function. Mucosal Immunology 2008, 1:11-22.
87. Madsen K.L., Malfair D., Gray D., Doyle J.S., Jewell L.D., Fedorak R.N. Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora. Inflammatory Bowel Diseases 1999, 5:262-270.
88. Maldonaldo-Bernal C., Kirschning C.J., Rosenstein Y., Rocha L.M., Rios-Sarabia N., Espinosa-Cantellano M., Becker I., Salazar-González R.M., López-Macías C., Wagner H., Sánchez J., Isibasi A. The innate immune response to Entamoeba histolytica lipopeptidophosphoglycan is mediated by toll-like receptors 2 and 4. Parasite Immunology 2005, 2:127-137.
89. Maloy K.J., Kullberg M.C. IL-23 and Th17 cytokines in intestinal homeostasis. Mucosal Immunology 2008, 5:339-349.
90. Marion S., Guillén N. Genomic and proteomic approaches highlight phagocytosis of living and apoptotic human cells by the parasite Entamoeba histolytica. International Journal of Parasitology 2006, 36:131-139.
91. Meresse B., Cerf-Bensussan N. Innate T cell responses in human gut. Seminars in Immunology 2009, 21:121-129.
92. Moncada D., Keller K., Chadee K. Entamoeba histolytica secreted products degrade colonic mucin oligosaccharides. Infection and Immunity 2005, 73:3790-3793.
93. Mora J.R., Iwata M., Eksteen B., Song S.Y., Junt T., Senman B., Otipoby K.L., Yokota A., Takeuchi H., Ricciardi-Castagnoli P., Rajewsky K., Adams D.H., von Andrian U.H. Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science 2006, 314:1157-1160.
94. Mostov K.E., Deitcher D.L. Polymeric immunoglobulin receptor expressed in MDCK cells transcytoses IgA. Cell 1986, 46:613-621.
95. Murray H.W., Aley S.B., Scott W.A. Susceptibility of Entamoeba histolytica to oxygen intermediates. Molecular and Biochemical Parasitology 1981, 3:381-391.
96. Nenci A., Becker C., Wullaert A., Gareus R., van Loo G., Danese S., Huth M., Nikolaev A., Neufert C., Madison B., Gumucio D., Neurath M.F., Pasparakis M. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 2007, 446:557-561.
97. Padilla-Vaca F., Ankri S., Bracha R., Koole A.L., Mirelman D. Down regulation of Entamoeba histolytica virulence by monoxenic cultivation with Escherichia coli O55 is related to a decrease in expression of the light (35-kilodalton) subunit of the Gal/GalNAc lectin. Infection and Immunity 1999, 67:2096-2102.
98. + T cell-mediated suppression by dendritic cells. Science 2003, 299:1033-1036.
99. Peterson D.A., McNulty N.P., Guruge J.L., Gordon J.I. IgA response to symbiotic bacteria as a mediator of gut homeostasis. Cell Host Microbe 2007, 2:328-339.
100. Petri W.A., Smith R.D., Schlesinger P.H., Murphy C.F., Ravdin J.I. Isolation of the galactose-binding lectin that mediates the in vitro adherence of Entamoeba histolytica. Journal of Clinical Investigation 1987, 80:1238-1244.
101. Petri W.A., Chapman M.D., Snodgrass T., Mann B.J., Broman J., Ravdin J.I. Subunit structure of the galactose and N-acetyl-d-galactosamine-inhibitable adherence lectin of Entamoeba histolytica. Journal of Biological Chemistry 1989, 264:3007.
102. Phalipon A., Ana Cardona A., Kraehenbuhl J., Edelman L., Sansonetti P.J., Corthésy B. Secretory component: a new role in secretory IgA-mediated immune exclusion in vivo. Immunity 2002, 17:107-115.
103. Powell S.J., Naeme P.B. A case of amoebic brain abscess. British Medical Journal 1960, 2:1136-1137.
104. Prathap K., Gilman R. The histopathology of acute intestinal amebiasis. American Journal of Pathology 1970, 60:229-246.
105. Que X., Reed S.L. Cysteine proteinases and the pathogenesis of amebiasis. Clinical Microbiology Reviews 2000, 13:196-206.
106. Ravdin J.I., Moreau F., Sullivan J.A., Petri W.A., Mandell G.L. Relationship of free intracellular calcium to the cytolytic activity of Entamoeba histolytica. Infection and Immunity 1988, 56:1505-1512.
107. Ravdin J.I., Abd-Alla M.D., Welles S.L., Reddy S., Jackson T.F. Intestinal anti-lectin immunoglobulin A antibody response and immunity to Entamoeba dispar infection following cure of amebic liver abscess. Infection and Immunity 2003, 71:6899-6905.
108. Reed S.L., Gigli I. Lysis of complement-sensitive Entamoeba histolytica by activated terminal complement components. Journal of Clinical Investigation 1990, 86:1815-1822.
109. Reed S.L., Curd J.G., Gigli I., Gillin F.D., Braude A.I. Activation of complement by pathogenic and nonpathogenic Entamoeba histolytica. Journal of Immunology 1986, 136:2265-2270.
110. Reed S.L., Keene W.E., McKerrow J.H., Gigli I. Cleavage of C3 by a neutral cysteine proteinase of Entamoeba histolytica. Journal of Immunology 1989, 143:189-195.
111. Reed S.L., Ember J., Herdman D., Discipio R., Hugli T., Gigli I. The extracellular neutral cysteine proteinase of Entamoeba histolytica degrade anaphylatoxins C3a and C5a. Journal of Immunology 1995, 155:266-274.
112. Riahi Y., Simon-Tov R., Ankri S. Molecular cloning, expression and characterization of a serine proteinase inhibitor gene from Entamoeba histolytica. Molecular and Biochemical Parasitology 2004, 133:153-162.
113. Rigothier M., Khun H., Tavares P., Cardona A., Huerre M., Guillén N. Fate of Entamoeba histolytica during establishment of amoebic liver abscess analyzed by quantitative radioimaging and histology. Infection and Immunity 2002, 70:3208-3215.
114. Rock E.P., Sibbald P.R., Davis M.M., Chien Y.H. CDR3 length in antigen-specific immune receptors. Journal Experimental Medicine 1994, 179:323-328.
115. Roncarolo M.G., Gregori S., Battaglia M., Bacchetta R., Fleischhauer K., Levings M.K. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunological Reviews 2006, 212:28-50.
116. Ruiz P.A., Shkoda A., Kim S.C., Sartor R.B., Haller D. IL-10 gene-deficient mice lack TGF-β/Smad signaling and fail to inhibit proinflammatory gene expression in intestinal epithelial cells after the colonization with colitogenic Enterococcus faecalis. Journal of Immunology 2005, 174:2990-2999.
117. Saffer L.D., Petri W.A. Role of the galactose lectin of Entamoeba histolytica in adherence-dependent killing of mammalian cells. Infection and Immunity 1991, 59:4681-4683.
118. Salata R.A., Ravdin J.I. Interaction of human neutrophils and Entamoeba histolytica and increases cytopathogenicity for liver cell monolayers. Journal of Infectious Diseases 1986, 154:19-26.
119. Salata R.A., Martinez-Palomo A., Murray H.W., Conales L., Trevino N., Segovia E., Murphy C.F., Ravdin J.I. Patients treated for amebic liver abscess develop cell mediated responses effective in vitro against Entamoeba histolytica. Journal of Immunology 1986, 136:2633-2639.
120. Salata R.A., Martinez-Palomo A., Canales L., Murray H.W., Trevino N., Ravdin J.I. Suppression of T-lymphocyte responses to Entamoeba histolytica antigen by immune Sera. Infection and Immunity 1990, 58:3941-3946.
121. Santi-Rocca J., Weber C., Guigon G., Sismeiro O., Coppée J.Y., Guillén N. The lysine and glutamic acid-rich protein KERP1 plays a role in Entamoeba histolytica liver abscess pathogenesis. Cellular Microbiology 2008, 10:202-217.
122. + cells that provide innate mucosal immune defense. Immunity 2008, 29:958-970.
123. Schwerbrock N.M., Makkink M.K., van der Sluis M., Buller H.A., Einerhand A.W., Sartor R.B., Dekker J. Interleukin 10-deficient mice exhibit defective colonic Muc2 synthesis before and after induction of colitis by commensal bacteria. Inflammatory Bowel Diseases 2004, 10:811-823.
124. Séguin R., Mann B.J., Keller K., Chadee K. Identification of the galactose-adherence lectin epitopes of Entamoeba histolytica that stimulate tumor necrosis factor-a production by macrophages. Proceedings of the National Academy of Sciences of USA 1995, 92:12175-12179.
125. Seydel K.B., Li E., Swanson P., Stanley S.L. Human intestinal epithelial cells produce proinflammatory cytokines in response to infection in a SCID mouse-human intestinal xenograft model of amebiasis. Infection and Immunity 1997, 65:1631-1639.
126. Seydel K.B., Zhang T., Stanley S.L. Neutrophils play a critical role in early resistance to amebic liver abscesses in severe combined immunodeficient mice. Infection and Immunity 1997, 65:3951-3953.
127. Seydel K.B., Li E., Zhang Z., Stanley S.L. Epithelial cell-initiated inflammation plays a crucial role in early tissue damage in amebic infection of human intestine. Gastroenterology 1998, 115:1446-1453.
128. Seydel K.B., Smith S.J., Stanley S.L. Innate immunity to amebic liver abscess is dependent on gamma interferon and nitric oxide in a murine model of disease. Infection and Immunity 2000, 68:400-402.
129. Shevach E.M. Mechanisms of Foxp3 T regulatory cell-mediated suppression. Immunity 2009, 30:636-645.
130. Sim S., Park S., Yong T., Im K., Shin M.H. Involvement of b2-integrin in ROS-mediated neutrophil apoptosis induced by Entamoeba histolytica. Microbes and Infection 2007, 9:1368-1375.
131. Siman-Tov R., Ankri S. Nitric oxide inhibits cysteine proteinases and alcohol dehydrogenase 2 of Entamoeba histolytica. Parasitology Research 2003, 89:146-149.
132. Snow M., Chen M., Guo J., Atkinson J., Stanley S. Short report: differences in complement-mediated Killing of Entamoeba histolytica between men and women-an explanation for the increased susceptibility of men to invasive amebiasis?. American Journal of Tropical Medicine and Hygiene 2008, 78:922-923.
133. Stanley S.L. Amoebiasis. Lancet 2003, 361:1025-1034.
134. Stanley S.L., Jackson T.F., Reed S.L., Calderón J., Kunz-Jenkins C., Gathiram V., Li E. Serodiagnosis of invasive amebiasis using a recombinant Entamoeba histolytica protein. The Journal of the American Medical Association 1991, 266:1984-1986.
135. Sullivan B.H., Bailey F.N. Amebic lung abscess. Chest 1951, 20:84-96.
136. Sun C.M., Hall J.A., Blank R.B., Bouladoux N., Oukka M., Mora J.R., Belkaid Y. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. Journal of Experimental Medicine 2007, 204:1775-1785.
137. Talamás-Rohana P., Hernández-Ramírez V.I., Pérez-García J.N., Ventura-Juárez J. Entamoeba histolytica contains a β1 integrin-like molecule similar to fibronectin receptors from eukaryotic cells. Journal of Eukaryotic Microbiology 1998, 45:356-360.
138. Teramoto K., Yamashita N., Kuwabara M., Hanawa T., Matsui T., Matsubara Y. An amebic lung abscess: report of a case. Surgery Today 2001, 31:820-822.
139. Tillack M., Nowak N., Lotter H., Bracha R., Mirelman D., Tannich E., Bruchhaus I. Increased expression of the major cysteine proteinases by stable episomal transfection underlines the important role of EhCP5 for the pathogenicity of Entamoeba histolytica. Molecular and Biochemical Parasitology 2006, 149:58-64.
140. Tran V.Q., Herdman S., Torian B.E., Reed S.L. The neutral cysteine proteinase of Entamoeba histolytica degrades IgG and prevents its binding. Journal of Infectious Diseases 1998, 177:508-511.
141. Velazquez C., Shibayama-Sala M., Aguirre-Garcia J., Tsutsumi V., Calderón J. Role of neutrophils in innate resistance to Entamoeba histolytica liver infection in mice. Parasite Immunology 1998, 20:255-262.
142. Ventura-Juárez J., Campos-Rodríguez R., Jarillo-Luna R.A., Muñoz-Fernández L., Escario-G-Trevijano J.A., Pérez-Serrano J., Quintana J.L., Salinas E., Villalobos-Gómez F.R. Trophozoites of Entamoeba histolytica express a CD59-like molecule in human colon. Parasitology Research 2009, 104:821-826.
143. Wagner H. Interactions between bacterial CpG-DNA and TLR9 bridge innate and adaptive immunity. Current Opinion in Microbiology 2002, 5:62-69.
144. Walport M.J. Complement: second of two parts. New England Journal of Medicine 2001, 344:1140-1144.
145. Wang W., Chadee K. Entamoeba histolytica suppresses gamma interferon-induced macrophage class II major histocompatibility complex Ia molecule and I-Ab mRNA expression by a prostaglandin E2-dependent mechanism. Infection and Immunity 1995, 63:1089-1094.
146. Wang W., Keller K., Chadee K. Entamoeba histolytica modulates the nitric oxide synthase gene and nitric oxide production by macrophages for cytotoxicity against amoebae and tumour cells. Immunology 1994, 83:601-610.
147. Weber C., Blazquez S., Marion S., Ausseur C., Vats D., Krzeminski M., Rigothier M., Maroun R.C., Bhattacharya A., Guillén N. Bioinformatics and functional analysis of an Entamoeba histolytica mannosyltransferase necessary for parasite complement resistance and hepatical infection. PLoS Neglected Tropical Diseases 2008, 2:e165.
148. WHO: Amoebiasis, 1997. WHO Weekly Epidemiologic Record, vol. 72. pp. 97-100.
149. Wilson M.S., Mentink-Kane M.M., Pesce J.T., Ramalingam T.R., Thompson R., Wynn T.A. Immunopathology of schistosomiasis. Immunology and Cell Biology 2007, 85:148-154.
150. Wittner M., Rosenbaum M. Role of bacteria in modifying virulence of Entamoeba histolytica studies of amebae from axenic cultures. American Journal Tropical Medicine Hygiene 1970, 19:755-761.
151. Yao C., Sakata D., Esaki Y., Li Y., Matsuoka T., Kuroiwa K., Sugimoto Y., Shuh Narumiya S. Prostaglandin E2-EP4 signaling promotes immune inflammation through TH1 cell differentiation and TH17 cell expansion. Nature Medicine 2009, 15:633-640.
152. Zhang Z., Yan L., Wang L., Seydel K.B., Li E., Ankri S., Mirelman D., Stanley S.L. Entamoeba histolytica cysteine proteinases with interleukin-1 beta converting enzyme (ICE) activity cause intestinal inflammation and tissue damage in amoebiasis. Molecular Microbiology 2000, 37:542-548.
153. Zhang X., Zhang Z., Alexander D., Bracha R., Mirelman D., Stanley S.L. Expression of amebapores is required for full expression of Entamoeba histolytica virulence in amebic liver abscess but is not necessary for the induction of inflammation or tissue damage in amebic colitis. Infection and Immunity 2004, 72:678-683.
154. Zheng Y., Valdez P.A., Danilenko D.M., Hu Y., Sa S.M., Gong Q., Abbas A.R., Modrusan Z., Ghilardi N., de Sauvage F.J., Ouyang W. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nature Medicine 2008, 14:282-289.
155. Zhou P., Streutker C., Borojevic R., Wang Y., Croitoru K. IL-10 modulates intestinal damage and epithelial cell apoptosis in T cell-mediated enteropathy. American Journal of Physiology 2004, 287:G599-G604.